RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Nextech Invest
N

Nextech Invest portfolio

Nextech Invest has 13 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 13.
Deals, last 12 months: 4.
Rounds led: 6 of 20.
Capital in their rounds: $2.21B.
Latest deal: Matchpoint Therapeutics · Oct 7, 2026.
About this page

It is a venture capital firm based in Zurich, CH, founded in 2006. It led 6 of the 20 rounds it joined. Its most recent investment on record is Matchpoint Therapeutics's $150M Series B+ round in October 2026, which it led, alongside Access Biotechnology, Digitalis Ventures, BOLD Longevity Growth Fund and 6 others. By category, its portfolio leans toward Health and bio (13) and Education (1). It has co-invested with Casdin Capital, Third Rock Ventures and The Column Group, most often Casdin Capital (6 rounds).

About Nextech Invest

Firm type: Venture capital.
Headquarters: Zurich, CH.
Founded: 2006.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: Biotech, Healthtech, Medical Devices.
Check size: $648K to $3.24M.
Portfolio companies: 65.
Exits: 13.
Rounds led: 6.

What Nextech Invest invests in

Nextech Invest recent investments

How Nextech Invest invests

StageDealsCapital in rounds
Series B+ 14 70%$1.73B
Series A 6 30%$474M
YearDealsCapital in rounds
2019 1 5%$57M
2020 2 10%$157.5M
2021 3 15%$220M
2022 2 10%$272M
2023 3 15%$245M
2024 4 20%$500M
2025 2 10%$480M
2026 3 15%$275M

Nextech Invest portfolio companies

CompanyRound with Nextech InvestTotal raisedLatest raise
MMatchpoint Therapeutics
Health and bio
Series B+ · $150M · lead$250MOct 7, 2026
Series B+
FFlare Therapeutics
Health and bio
Series B+ · $85M · lead$167MJun 30, 2026
Series B+
AAtavistik Bio
Health and bio
Series B+ · $40M$220MMar 5, 2026
Series B+
TTubulis
Health and bio
Series B+ · $360M$573MOct 16, 2025
Series B+
AAlpha-9 Oncology
Health and bio
Series B+ · $175M$175MOct 23, 2024
Series B+
IIDRx
Health and bio
Series B+ · $120M$242MAug 8, 2024
Series B+
DDelphia Therapeutics
Health and bio
Series A · $67M$67MMay 2, 2024
Series A
MMariana Oncology
Health and bio
Series B+ · $175M$175MSep 7, 2023
Series B+
KK36 Therapeutics
Health and bio
Series B+ · $70M · lead$100MJun 28, 2023
Series B+
MMOMA Therapeutics
Health and bio
Series B+ · $150M$236MMay 10, 2022
Series B+
EExo Therapeutics
Health and bio
Series B+ · $78M · lead$103MOct 5, 2021
Series B+
AA2 Biotherapeutics
Health and bio
Series B+ · $71.5M$270.5MJan 10, 2025
Series B+
KKhartis Therapeutics
Health and bio
backer$95MAug 13, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 20 rounds on Recent Funding that name Nextech Invest. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Nextech Invest, which is a subset of its real portfolio. API: /api/v1/investors/nextech-invest (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy